Status:
NOT_YET_RECRUITING
Nebulized Dexmedetomidine or Lidocaine for Treatment of Post Dural Puncture Headache in Parturients Undergoing Elective Cesarean Section Under Spinal Anesthesia
Lead Sponsor:
Minia University
Conditions:
Pain Score (VAS)
Eligibility:
FEMALE
20-40 years
Phase:
EARLY_PHASE1
Brief Summary
Post-dural puncture headache (PDPH) is a well-recognized and potentially serious complication of subarachnoid block. While advancements in spinal needle design have reduced its incidence in recent yea...
Eligibility Criteria
Inclusion
- Post partum headache for parturient with elective CS under spinal anesthesia with visual analog score (VAS) ≥ 4 \[14\] and Lybecker classification score ≥ 2
Exclusion
- Emergency caesarean section.
- Pregnancy induced hypertension
- Contraindications for sub-arachinoid block ( coagulopathy, infection )
- History of chronic headache, migraine, trigeminal neuralgia
- Refusal to participate
- History of cerebrovascular stroke
- BMI\> 35
- History of obstructive sleep apnea.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 5 2025
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT06607861
Start Date
October 1 2024
End Date
October 5 2025
Last Update
September 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.